We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.15B
AUM Growth
+$59M
Cap. Flow
-$87.2M
Cap. Flow %
-7.58%
Top 10 Hldgs %
12.78%
Holding
1,132
New
384
Increased
172
Reduced
194
Closed
306

Top Buys

Rank Stock Value
1
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$12.8M
2
JIH.U
Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00
JIH.U
+$9.53M
3
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
+$8.79M
4
AMZN icon
Amazon
AMZN
+$6.74M
5
BABA icon
Alibaba
BABA
+$6.59M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$15.9M
2
CELG
Celgene Corp
CELG
+$15M
3
AABA
Altaba Inc
AABA
+$10.1M
4
BMTX
BM Technologies, Inc.
BMTX
+$9.25M
5
GCMG icon
GCM Grosvenor
GCMG
+$8.1M

Sector Composition

Rank Sector Weight
1 Technology 13.52%
2 Healthcare 10.04%
3 Consumer Discretionary 6.7%
4 Real Estate 4.77%
5 Communication Services 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOGI icon
551
Logitech
LOGI
$14.7B
$379K 0.03%
+8,039
New +$343K
ROP icon
552
Roper Technologies
ROP
$38.6B
$379K 0.03%
+1,070
New +$370K
FPAC.WS
553
DELISTED
Far Point Acquisition Corporation Warrants, exercisable for one share of Class A Common Stock for $1
FPAC.WS
$379K 0.03%
36,652
+6,830
+23% +$8.36K
RLI icon
554
RLI Corp
RLI
$5.58B
$376K 0.03%
+8,348
New +$392K
KDNY
555
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$376K 0.03%
63,747
+48,788
+326% +$265K
ACN icon
556
Accenture
ACN
$99.4B
$374K 0.03%
+1,776
New +$346K
HCA icon
557
HCA Healthcare
HCA
$85.5B
$370K 0.03%
2,502
+340
+16% +$45.7K
GNW icon
558
Genworth Financial
GNW
$3.77B
$367K 0.03%
+83,490
New +$351K
UTI icon
559
Universal Technical Institute
UTI
$2.16B
$367K 0.03%
+47,597
New +$287K
PRKS icon
560
United Parks & Resorts
PRKS
$2.1B
$366K 0.03%
11,552
-1,366
-11% -$39.4K
NRXPW
561
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$362K 0.03%
34,163
– –
TPIC
562
DELISTED
TPI Composites
TPIC
$359K 0.03%
19,408
+6,815
+54% +$125K
SCHW
563
Charles Schwab
SCHW
$182B
$358K 0.03%
+7,519
New +$331K
PRQR icon
564
ProQR Therapeutics
PRQR
$243M
$357K 0.03%
+36,051
New +$281K
RARE icon
565
Ultragenyx Pharmaceutical
RARE
$2.45B
$354K 0.03%
+8,289
New +$342K
OCUL icon
566
Ocular Therapeutix
OCUL
$1.82B
$352K 0.03%
89,077
-1,450
-2% -$5.04K
EFX icon
567
Equifax
EFX
$20.4B
$348K 0.03%
+2,483
New +$344K
CVET
568
PUT
DELISTED
Covetrus, Inc. Common Stock
CVET
$343K 0.03%
+260
New +$3.15K
HIO
569
Western Asset High Income Opportunity Fund
HIO
$334M
$342K 0.03%
67,500
– –
FUNC icon
570
First United
FUNC
$281M
$341K 0.03%
+14,148
New +$335K
ISRG icon
571
Intuitive Surgical
ISRG
$125B
$339K 0.03%
+1,722
New +$322K
XMMO icon
572
Invesco S&P MidCap Momentum ETF
XMMO
$7.08B
$338K 0.03%
+5,532
New +$328K
SECO
573
DELISTED
Secoo Holding Limited ADR
SECO
$336K 0.03%
5,708
+723
+15% +$42.9K
ADXS
574
DELISTED
Advaxis Inc
ADXS
$336K 0.03%
391,248
-1,399
-0.4% -$638
B
575
Barrick Mining
B
$61.1B
$335K 0.03%
18,046
+446
+3% +$7.66K
21 22
23
24 25

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Boothbay Fund Management's Q4 2019 Portfolio in Review

As of Q4 2019, Boothbay Fund Management held 1,132 positions worth $1.15B, up 5.4% from $1.09B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boothbay Fund Management withdrew a net $87.2M in Q4 2019, closing 306 positions and reducing 194 holdings. Its most notable exit was Celgene Corp, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00 worth $9.4M.

  • Boothbay Fund Management's largest Q4 2019 buy was Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00: 949,000 shares worth $9.4M.
  • Boothbay Fund Management added most to Sprott Physical Gold and Silver Trust in Q4 2019, an estimated $12.8M increase.
  • Boothbay Fund Management's biggest Q4 2019 reduction was Alphabet (Google) Class A, cutting an estimated $15.9M.
  • Boothbay Fund Management fully exited Celgene Corp in Q4 2019, selling an estimated $15M.
  • Boothbay Fund Management's ten largest holdings make up 13% of its $1.15B portfolio in Q4 2019.
  • Boothbay Fund Management opened 384 new positions and closed 306 in Q4 2019.
  • Boothbay Fund Management's portfolio value rose 5.4% quarter-over-quarter to $1.15B.

Based on Boothbay Fund Management's 13F filing for Q4 2019, filed 14 Feb 2020.